| Filed On | Filing |
|---|---|
| 16 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On September 15, 2026 (the “Effective Date”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Avalyn Pharma Inc. (the “Company”), the Board appointed Robert Meyer, M... |
| 12 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 01 Jul 2026 | 8-K: Entry into a Material Definitive Agreement |
| 17 Jun 2026 | 8-K: Regulation FD Disclosure |
| 03 Jun 2026 | 8-K: Results of Operations and Financial Condition |
| 01 May 2026 | 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year |
Loading...
